NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.
The NCCN Guidelines for Hematopoietic Cell Transplantation (HCT) provide an evidence- and consensus-based approach for the use of autologous and allogeneic HCT in the management of malignant diseases in adult patients. HCT is a potentially curative treatment option for patients with certain types of malignancies; however, recurrent malignancy and transplant-related complications often limit the long-term survival of HCT recipients. The purpose of these guidelines is to provide guidance regarding aspects of HCT, including pretransplant recipient evaluation, hematopoietic cell mobilization, and treatment of graft-versus-host disease-a major complication of allogeneic HCT-to enable the patient and clinician to assess management options in the context of an individual patient's condition. These NCCN Guidelines Insights provide a summary of the important recent updates to the NCCN Guidelines for HCT, including the incorporation of a newly developed section on the Principles of Conditioning for HCT.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Transplantation, Homologous
- Transplantation Conditioning
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Humans
- Hematopoietic Stem Cell Transplantation
- Graft vs Host Disease
- Adult
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Transplantation, Homologous
- Transplantation Conditioning
- Oncology & Carcinogenesis
- Neoplasm Recurrence, Local
- Humans
- Hematopoietic Stem Cell Transplantation
- Graft vs Host Disease
- Adult
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis